| 12 column results |
|
-
Contributor: Peter Boogaard
Posted: 02/20/2012 4:57:50 AM EST
Implementing QbD Initiatives: But what is Quality? How do you measure Quality? Is Quality related to a product, a process or a system or all above? The Quality Transformation is a culture of commitment to continual improvement read more
-
Contributor: Cristina Falcão
Posted: 02/16/2012 6:33:29 AM EST
Big Pharma Cannot Afford to be Lost in Translation: Since more and more clinical research and drug manufacturing are being done in multiple countries and in multiple languages, quality language services can help bring a drug to market faster, and can help streamline the clinical trial process. Translation may be required at many stages, including clinical research, regulatory submission and review, production and marketing. read more
-
Contributor: Stuart Carroll & Alasdair Williams
Posted: 02/08/2012 4:09:38 AM EST
Value-Based Pricing in 2012 – Is it Still Worth the Trouble?: As the old aphorism goes, a New Year means a new beginning. It also provides an opportunity for all of us to make New Year resolutions – promises we make to one or more lasting personal goals, projects, or the reforming of a habit. In the world of health policy, this has added meaning. The Government continues to face opposition to its NHS reforms. read more
-
Contributor: Anthony Chambers
Posted: 01/25/2012 4:14:40 AM EST
Sustain Your ELN – Before You Start Your ELN: Change management can be found as a bullet under “critical success factors” in many Electronic Lab Notebook project charters. Touted as crucial in determining the success of an ELN, many agree in principle that change management is needed, but don’t know how to go about making it effective, tangible, and measurable. read more
-
Contributor: Jon Wetzel
Posted: 01/23/2012 7:46:13 AM EST
Being An Instrument of Change: Ask your colleague, “How can I make it easier for you when transferring over these products?” By doing this you are making the job easier for you and for them. How? read more
-
Contributor: John Trigg
Posted: 12/20/2011 9:13:57 AM EST
Peace in our Time? R&D and the IT Department: One of the consequences of the increasing convergence of science and technology is the nature of the relationship between R&D and IT. As scientists increasingly depend on information technology as an integral component of laboratory work, they become increasingly dependent on the IT infrastructure and IT resources. read more
-
Contributor: Eric Langer
Posted: 12/15/2011 11:27:03 AM EST
Biopharma Suppliers’ Budgets Increase: Bellwether for Better Times: Biopharmaceutical companies have weathered a rough recession, layoffs, and budget trimmings. These cutbacks have affected their vendors as well. In BioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing, we surveyed 352 biotherapeutic manufacturers, and 180 of their vendors, in 32 countries. The substantial budget cuts at vendors that started in 2008 have begun to turn around. We measured 10 budget areas for vendors to this industry. Sales budgets, the only area that did not take a downturn, continued to increase, this year, by an average of 5% globally. read more
-
Contributor: Mollie Shields-Uehling
Posted: 11/30/2011 7:08:25 AM EST
What Every CRO Should Know When Becoming Fully Electronic: As the global CRO community studies how to most efficiently move to fully electronic business processes, there are numerous issues that must be addressed to assure secure global collaboration. These include identity trust, data integrity, regulatory compliance, and time and cost savings. read more
-
Contributor: Amy Patel
Posted: 09/20/2011 8:24:55 AM EDT
The Future Potential of Human Limb Regeneration: Salamanders and newts can regenerate missing legs, tails and eyes in just weeks! Why can’t mammals possess the same super powers of regeneration as these smaller animals? read more
-
Contributor: Alpesh Pathak
Posted: 07/15/2011 5:02:00 AM EDT
Patent Drafting and Claim Construction: To determine whether the patentee has right to exclude for a particular claimed invention, it is essential to know what is claimed and this process is called determining the scope of the invention or claims construction. read more
-
Contributor: Elie Magdalani
Posted: 07/04/2011 4:36:32 AM EDT
Pharmacoepidemiology and Pharmacovigilance: As an important arm for pharmacovigilance, recently many voices are raised to consider using clinical trials in the post-marketing surveillance phase and not only depending on non-clinical or experimental methods to study drug safety issues after marketing the drug. read more
| 12 column results |
|
-
2nd Annual Bio/Pharmaceutical Cold Chain China 2012
Renaissance Beijing Capital Hotel, Beijing, China
February 28- 29, 2012 -
10th Annual Cold Chain Management & Temperature Control Summit - Canada
Hyatt Regency, Toronto, Canada
February 27- 1, 2012 -
Cold Chain Global Forum 2012
September 17- 21, 2012 -
2nd Annual Pharma Regulatory Affairs Asia
Amara Singapore Hotel, Singapore
April 25- 26, 2012
-
Do’s and Don’ts for Strategic Planning of Laboratory Informatics
laboratory informatics | informatics | Kevin Gillespie
-
Big Pharma Cannot Afford to be Lost in Translation
Cristina Falcão
-
Are You Up to Date with Health Canada's Guidelines for Temperature Control Storage and Distribution?
cold chain | Health Canada | temperature control storage








Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!